To evaluate the association between metabolic syndrome (MetS) and severe maternal morbidity (SMM) in pregnant patients of advanced maternal age (AMA), highlighting the significance of this relationship for clinical outcomes.
Key Findings:
Metabolic syndrome is the strongest independent predictor of severe maternal morbidity among patients of advanced maternal age, indicating a critical area for intervention.
The odds of severe maternal morbidity increase nearly threefold with metabolic syndrome, surpassing the risk associated with age alone, underscoring the need for targeted screening.
Interpretation:
Incorporating preconception and prenatal screening for metabolic syndrome components into routine care for advanced maternal age patients could improve risk stratification and management, ultimately enhancing maternal health outcomes.
Limitations:
The study is limited to delivery hospitalizations and does not capture antenatal admissions, which may overlook important risk factors.
The NIS database lacks unique patient identifiers, preventing linkage of hospitalizations across individuals, which could introduce biases in the findings.
Conclusion:
The findings underscore the importance of recognizing metabolic syndrome in older pregnant patients to mitigate risks of severe maternal morbidity, advocating for its integration into clinical practice.
